Citrate Anticoagulation for Postdilution Hemofiltration
NCT03969966 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-05-11
Summary
This study evaluates a protocol for regional citrate anticoagulation in critically ill patients with acute kidney injury who are treated with continuous veno-venous haemofiltration in postdilution mode.
Conditions
- Acute Kidney Injury
- Critical Illness
Interventions
- OTHER
-
renal replacement therapy as clinically indicated
Continuous renal replacement therapy
Sponsors & Collaborators
-
Diamed GmbH, Cologne, Germany
collaborator UNKNOWN -
Heinrich-Heine University, Duesseldorf
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-14
- Primary Completion
- 2020-12-31
- Completion
- 2021-07-31
Countries
- Germany
Study Locations
More Related Trials
-
Multi-center Study to Investigate the Effects of Citrasate® on Heparin N Requirements During Hemodialysis Treatment
NCT01092455 ·Status: COMPLETED
-
Metabolic Aspects of Citrate Anticoagulation in Renal Replacement Therapy
NCT01361581 ·Status: UNKNOWN
-
Remote Ischemic Preconditioning to Prevent Contrast Nephropathy
NCT02674451 ·Status: TERMINATED ·Phase: NA
-
Effect of Citrate Dialysate on Vascular Calcification
NCT04956120 ·Status: COMPLETED ·Phase: NA
-
Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
NCT05382078 ·Status: UNKNOWN
-
The Impact of Different Citrate Concentrations as Locking Solutions on Development of Biofilm and Function of Hemodialysis Catheters
NCT03683563 ·Status: UNKNOWN ·Phase: NA
-
Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement
NCT03121053 ·Status: UNKNOWN ·Phase: PHASE4
-
The Acetylcysteine for Contrast-Induced Nephropathy Trial
NCT00736866 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Remote Ischemic Preconditioning on Elective Percutaneous Coronary Intervention in Diabetic Nephropathy
NCT02329444 ·Status: COMPLETED ·Phase: NA
-
Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiography
NCT02463604 ·Status: COMPLETED ·Phase: NA
-
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627 ·Status: COMPLETED ·Phase: NA
-
Ischemic Preconditioning for Prevention of Contrast Nephropathy in The Emergency Department
NCT03238391 ·Status: UNKNOWN ·Phase: NA
-
Can Remote Ischaemic Preconditioning Reduce Contrast Induced Nephropathy in Patients Receiving Contrast for Computed Tomography?
NCT01741896 ·Status: COMPLETED ·Phase: NA
-
Biochemical Effects of Remote Ischemic Pre-Conditioning on Contrast-induced Acute Kidney Injury
NCT03236441 ·Status: COMPLETED ·Phase: NA
-
Regional Citrate Anticoagulation in Plasma Exchange Treatment
NCT01370200 ·Status: COMPLETED ·Phase: NA
-
Safe Use of Heparin Sodium in Patients With Chronic Renal Failure.
NCT01229072 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
The Effect of Whole Blood Viscosity on Contrast-Induced Nephropathy Development in Patients Undergoing Percutaneous Coronary Intervention
NCT04703049 ·Status: COMPLETED
-
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
NCT02468401 ·Status: COMPLETED ·Phase: NA
-
Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention
NCT04806633 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients
NCT02106962 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety and Pharmacokinetics of Tinzaparin During Slow Low Efficient Daily Dialysis in Intensive Care Patients
NCT03614741 ·Status: RECRUITING ·Phase: PHASE4
-
Methylene Blue for the Prevention of Hypotension During Hemodialysis
NCT05092165 ·Status: COMPLETED ·Phase: PHASE2
-
Hemofiltration for Contrast-Induced Nephropathy
NCT00158080 ·Status: UNKNOWN ·Phase: NA
-
Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients
NCT01017796 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients (IDPC Trial)
NCT02991742 ·Status: UNKNOWN